Top

Published in:

03-02-2024 | Leukemia | Letter to the Editor

Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage

Authors: Edwin Uriel Suárez, Miguel Ángel Piris, Socorro María Rodríguez-Pinilla, Juan F. García, José Luis López-Lorenzo, Javier Cornago-Navascués, Rocío Salgado-Sánchez, Tamara Castaño-Bonilla, Raquel Mata-Serna, Juan M. Alonso-Domínguez, Pilar Llamas

Published in: Annals of Hematology | Issue 5/2024

Excerpt

Dear editor, …

Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia 36(7):1703–1719. https://doi.org/10.1038/s41375-022-01613-1CrossRefPubMedPubMedCentral

Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR et al (2022) International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200–1228. https://doi.org/10.1182/blood.2022015850CrossRefPubMedPubMedCentral

Schwaab J, Knut M, Haferlach C, Metzgeroth G, Horny HP et al (2015) Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes. Ann Hematol 94(2):233–238. https://doi.org/10.1007/s00277-014-2221-yCrossRefPubMed

Metzgeroth G, Steiner L, Naumann N, Lübke J, Kreil S et al (2023) Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort. Leukemia. https://doi.org/10.1038/s41375-023-01958-1CrossRefPubMedPubMedCentral

He R, Greipp PT, Rangan A, Mai M, Chen D et al (2016) BCR-JAK2 fusion in a myeloproliferative neoplasm with associated eosinophilia. Cancer Genet 209(5):223–228. https://doi.org/10.1016/j.cancergen.2016.03.002CrossRefPubMed

Tang G, Sydney Sir Philip JK, Weinberg O, Tam W, Sadigh S et al (2019) Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study. Mod Pathol 32(4):490–498. https://doi.org/10.1038/s41379-018-0165-9CrossRefPubMed

Reiter A, Gotlib J (2017) Myeloid neoplasms with eosinophilia. Blood 129(6):704–714. https://doi.org/10.1182/blood-2016-10-695973CrossRefPubMed

Pozdnyakova O, Orazi A, Kelemen K, King R, Reichard KK et al (2021) Myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of PDGFRA, PDGFRB, or FGFR1 or with PCM1-JAK2. Am J Clin Pathol 155(2):160–178. https://doi.org/10.1093/ajcp/aqaa208CrossRefPubMed

Schwaab J, Naumann N, Luebke J, Jawhar M, Somervaille TCP et al (2020) Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes. Am J Hematol 95(7):824–833. https://doi.org/10.1002/ajh.25825CrossRefPubMed

10.

Lane SW, Fairbairn DJ, McCarthy C, Nandini A, Perry-Keene J et al (2008) Leukaemia cutis in atypical chronic myeloid leukaemia with a t(9;22) (p24;q11.2) leading to BCR-JAK2 fusion. Br J Haematol 142(4):503. https://doi.org/10.1111/j.1365-2141.2008.07164.xCrossRefPubMed

11.

Iacobucci I, Witkowski MT, Mullighan CG (2023) Single-cell analysis of acute lymphoblastic and lineage-ambiguous leukemia: approaches and molecular insights. Blood 141(4):356–368. https://doi.org/10.1182/blood.2022016954CrossRefPubMed

12.

Tzankov A, Reichard KK, Hasserjian RP, Arber DA, Orazi A et al (2023) Updates on eosinophilic disorders. Virchows Arch 482(1):85–97. https://doi.org/10.1007/s00428-022-03402-8CrossRefPubMed

13.

Chamseddine AN, Etancelin P, Penther D, Parmentier F, Kuadjovi C et al (2015) Transformation of an unclassified myeloproliferative neoplasm with a rare BCR-JAK2 fusion transcript resulting from the translocation (9;22)(p24;q11). Case Rep Hematol 2015:252537. https://doi.org/10.1155/2015/252537CrossRefPubMedPubMedCentral

14.

Bain BJ, Ahmad S (2014) Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities? Br J Haematol 166(6):809–817. https://doi.org/10.1111/bjh.12963CrossRefPubMed

15.

Chen JA, Hou Y, Roskin KM, Arber DA, Bangs CD et al (2021) Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance. Blood Adv 5(17):3492–3496. https://doi.org/10.1182/bloodadvances.2020004174CrossRefPubMedPubMedCentral

16.

Tefferi A, Alkhateeb H, Gangat N (2023) Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm. Blood Cancer J 13(1):108. https://doi.org/10.1038/s41408-023-00878-8CrossRefPubMedPubMedCentral

Title: Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage
Authors: Edwin Uriel Suárez
Miguel Ángel Piris
Socorro María Rodríguez-Pinilla
Juan F. García
José Luis López-Lorenzo
Javier Cornago-Navascués
Rocío Salgado-Sánchez
Tamara Castaño-Bonilla
Raquel Mata-Serna
Juan M. Alonso-Domínguez
Pilar Llamas
Publication date: 03-02-2024
Publisher: Springer Berlin Heidelberg
Keywords: Leukemia
Eosinophilia
Fluorescence in Situ Hybridization
Published in: Annals of Hematology / Issue 5/2024
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-024-05647-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2024

The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study

Autotaxin is a potential predictive marker for the development of veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation

Correction to: Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patientreported outcomes from the CARDINAL study

Epigenetic alterations and advancement of lymphoma treatment

Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report

Epidemiological features and a survival nomogram for primary lymphoma of the male genital tract

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage